RecruitingPhase 4NCT07263035

Urine Sodium-Driven Diuretic Adjustment Strategy in Acute Decompensated Heart Failure


Sponsor

Lakeland Regional Health Systems, Inc.

Enrollment

600 participants

Start Date

Apr 1, 2026

Study Type

INTERVENTIONAL

Conditions

Summary

The goal of this clinical trial is to learn if increasing the dose of diuretics to achieve a higher urine sodium target produces better clinical results when treating patients hospitalized with acute heart failure when compared to lower urine sodium target and standard of care. The main questions it aims to answer are: 1. Does targeting a higher urine sodium goal achieve greater natriuresis and diuresis? 2. Does targeting a higher urine sodium goal reduce frequency of hospital readmissions? 3. Does targeting a higher urine sodium goal reduce hospital length of stay? Researchers will compare natriuresis-guided arms with standard of care to see if targeting higher natriuresis goals improves significantly over current practice. Participants will submit urine samples at routine intervals after being given diuretics to evaluate urine sodium concentration. If urine sodium is low then diuretic dose will be increased.


Eligibility

Min Age: 18 Years

Inclusion Criteria8

  • The study will target adults 18 years of age or older admitted to Lakeland Regional Medical Center who:
  • Have a primary diagnosis of acute decompensated heart failure, and
  • Have at least one of the following signs of hypervolemia:
  • Bilateral lower extremity pitting edema
  • Jugular venous distension
  • Hepatojugular reflex
  • Crackles on pulmonary exam, or
  • Chest x-ray demonstrating pulmonary edema or pleural effusions

Exclusion Criteria8

  • Admission to the intensive care unit
  • Presence of ST-elevated myocardial infarction
  • Presence of type 1 non-ST elevated myocardial infarction
  • Dyspnea primarily due to non-cardiac cause as judged by the emergency medicine physician or admitting physician
  • Use of supplemental oxygen totaling at least 3 L per minute or greater at baseline
  • Anuria
  • End-stage renal disease per KDIGO criteria
  • Dialysis use

Interested in this trial?

Get notified about updates and connect with the research team.

Interventions

DRUGFurosemide intravenous solution

Diuretics will be titrated to achieve a urine sodium concentration of 50 mmol/L

DRUGFurosemide intravenous solution

Diuretics will be titrated to achieve a urine sodium concentration of 85 mmol/L

DRUGFurosemide intravenous solution

Standard of care


Locations(1)

Lakeland Regional Hospital

Lakeland, Florida, United States

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT07263035


Related Trials